F
$ Value
$3K
Shares
313
Price
$8
Filed
Mar 3
Insider
Name
Glessner Coleen
Title
EVP, Quality & Ethics, and CPL
CIK
0001919170
Roles
Officer
Transaction Details
Transaction Date
2026-03-01
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
112,307
Footnotes
Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units.
Filing Info
Glessner Coleen's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | EBS | F | $69K |
| 2026-03-03 | EBS | A | $0 |
| 2026-03-01 | EBS | F | $3K |
| 2026-02-06 | EBS | D | $315K |
| 2026-02-06 | EBS | F | $31K |
| 2025-10-07 | EBS | ▼ | $306K |
| 2025-06-08 | EBS | F | $8K |
Other Insiders at EBS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FOWLER JOHN D JR | — | — | 2026-03-03 |
|
LINDAHL RICHARD S
EVP, Chief Financial Officer
|
— | — | 2026-03-05 |
|
PAPA JOSEPH C
President and CEO
|
— | — | 2026-03-05 |
|
Glessner Coleen
EVP, Quality & Ethics, and CPL
|
— | — | 2026-03-05 |
|
Williams Paul Anthony
SVP, Products Business
|
— | $34K | 2026-04-01 |
|
Hartzel William
SVP, Bioservices
|
— | — | 2026-03-05 |
|
Perl Jessica
SVP, General Counsel, Corp Sec
|
— | — | 2026-03-05 |
|
Lowry Simon C
SVP, R&D, CMO
|
— | — | 2026-03-05 |